N. Levin

Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.

R. Bremnes, O. Brustugun, B. Grønberg, 2018, Anticancer research.

Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer.

S. Kaasa, R. Bremnes, O. Brustugun, 2016, Lung cancer.

Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.

Jan Nyman, Karl-Axel Johansson, Lars Ekberg, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Perspectives on divergence of early developmental regulatory pathways: Insight from the evolution of echinoderm double negative gate.

H. Wada, N. Levin, Yoshiaki Morino, 2022, Current topics in developmental biology.

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.

Jan Nyman, Karl-Axel Johansson, Lars Ekberg, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction

Jan Nyman, Lars Ekberg, Christer Sederholm, 2011, Acta oncologica.

Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer

I. Lax, R. Lewensohn, L. Ekberg, 2006, Acta oncologica.